Kinarus Therapeutics Holding AG
SIX:KNRS

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:KNRS
Watchlist
Price: 15 CHF 416 566.67% Market Closed
Market Cap: 19.5B CHF
Have any thoughts about
Kinarus Therapeutics Holding AG?
Write Note

Profitability Summary

Kinarus Therapeutics Holding AG's profitability score is 36/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score
36/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Kinarus Therapeutics Holding AG

Revenue
0 CHF
Operating Expenses
-13.9m CHF
Operating Income
-13.9m CHF
Other Expenses
-6k CHF
Net Income
-13.9m CHF

Margins Comparison
Kinarus Therapeutics Holding AG Competitors

Country CH
Market Cap 19.5B CHF
Operating Margin N/A
Net Margin N/A
Country US
Market Cap 36.9B USD
Operating Margin
9%
Net Margin
8%
Country US
Market Cap 25.7B USD
Operating Margin
8%
Net Margin
5%
Country IE
Market Cap 15.4B EUR
Operating Margin
15%
Net Margin
14%
Country US
Market Cap 18.4B USD
Operating Margin
-1%
Net Margin
0%
Country IN
Market Cap 1.6T INR
Operating Margin
15%
Net Margin
11%
Country CN
Market Cap 106.5B CNY
Operating Margin
1%
Net Margin
0%
Country SG
Market Cap 19.2B SGD
Operating Margin
14%
Net Margin
14%
Country UK
Market Cap 10.4B GBP
Operating Margin
10%
Net Margin
7%
Country CN
Market Cap 83B CNY
Operating Margin
3%
Net Margin
-1%
Country TR
Market Cap 378.5B TRY
Operating Margin
11%
Net Margin
29%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Kinarus Therapeutics Holding AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Kinarus Therapeutics Holding AG
SIX:KNRS
19.5B CHF
-237%
-220%
-237%
-248%
US
Delta Air Lines Inc
NYSE:DAL
36.9B USD
41%
6%
12%
7%
US
United Airlines Holdings Inc
NASDAQ:UAL
25.7B USD
27%
4%
10%
7%
IE
Ryanair Holdings PLC
LSE:RYA
15.4B EUR
29%
11%
21%
16%
US
Southwest Airlines Co
NYSE:LUV
18.4B USD
0%
0%
-2%
-4%
IN
Interglobe Aviation Ltd
NSE:INDIGO
1.6T INR
-368%
11%
24%
28%
CN
Air China Ltd
SSE:601111
106.5B CNY
-1%
0%
0%
1%
SG
Singapore Airlines Ltd
SGX:C6L
19.2B SGD
15%
6%
8%
9%
UK
International Consolidated Airlines Group SA
LSE:IAG
10.4B GBP
77%
6%
17%
13%
CN
China Southern Airlines Co Ltd
SSE:600029
83B CNY
-7%
-1%
3%
-8%
TR
Turk Hava Yollari AO
IST:THYAO.E
378.5B TRY
46%
18%
10%
15%
Country CH
Market Cap 19.5B CHF
ROE
-237%
ROA
-220%
ROCE
-237%
ROIC
-248%
Country US
Market Cap 36.9B USD
ROE
41%
ROA
6%
ROCE
12%
ROIC
7%
Country US
Market Cap 25.7B USD
ROE
27%
ROA
4%
ROCE
10%
ROIC
7%
Country IE
Market Cap 15.4B EUR
ROE
29%
ROA
11%
ROCE
21%
ROIC
16%
Country US
Market Cap 18.4B USD
ROE
0%
ROA
0%
ROCE
-2%
ROIC
-4%
Country IN
Market Cap 1.6T INR
ROE
-368%
ROA
11%
ROCE
24%
ROIC
28%
Country CN
Market Cap 106.5B CNY
ROE
-1%
ROA
0%
ROCE
0%
ROIC
1%
Country SG
Market Cap 19.2B SGD
ROE
15%
ROA
6%
ROCE
8%
ROIC
9%
Country UK
Market Cap 10.4B GBP
ROE
77%
ROA
6%
ROCE
17%
ROIC
13%
Country CN
Market Cap 83B CNY
ROE
-7%
ROA
-1%
ROCE
3%
ROIC
-8%
Country TR
Market Cap 378.5B TRY
ROE
46%
ROA
18%
ROCE
10%
ROIC
15%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top